Chinese Society of Clinical Oncology Breast Cancer(CSCO BC)Guidelines in 2024:International Contributions from China  

作　　者：Jianbin Li Zefei Jiang 

机构地区：[1]Senior Department of Oncology,Fifth Medical Center of PLA General Hospital,Beijing 100071,China [2]Department of Medical Molecular Biology,Beijing Institute of Biotechnology,Academy of Military Medical Sciences,Beijing 100071,China

出　　处：《Cancer Biology & Medicine》2024年第10期838-843,共6页癌症生物学与医学（英文版）

基　　金：supported by the China Postdoctoral Science Foundation(Grant No.2023T160788);the Beijing Science and Technology Plan(Grant No.Z181100001718215).

摘　　要：The Chinese Society of Clinical Oncology Breast Cancer(CSCO BC)guidelines have been widely implemented in China since the first release in 2017.The Guideline Working Committee has also published multiple versions in English,Arabic,and other languages to facilitate communications with international experts.

关 键 词：Cancer BREAST Clinical 

分 类 号：R737.9[医药卫生—肿瘤]